Analyst Coverage
| Firm | Analyst |
|---|---|
|
Baird
|
Brian Skorney
|
|
Bank of America Merrill Lynch
|
Geoff Meacham
|
|
Barclays
|
Gena Wang
|
|
BMO Capital Markets
|
Do Kim
|
|
Cantor
|
Alethia Young
|
|
Citi Research
|
Mohit Bansal
|
|
Cowen & Co.
|
Phil Nadeau, Ph.D.
|
|
Credit Suisse
|
Evan Seigerman
|
|
Evercore ISI
|
Liisa Bayko
|
|
Goldman Sachs
|
Salveen Richter
|
|
Guggenheim Securities
|
Etzer Darout
|
|
HC Wainwright
|
Andrew Fein
|
|
Jefferies
|
Michael Yee
|
|
J.P. Morgan
|
Cory W. Kasimov
|
|
Leerink
|
Geoff Porges, Ph.D.
|
|
Maxim Group
|
Jason McCarthy
|
|
Morgan Stanley
|
Matthew Harrison
|
|
Needham & Company
|
Alan Carr, Ph.D.
|
|
Oppenheimer
|
Hartaj Singh
|
|
Piper Jaffray
|
Edward Tenthoff
|
|
RBC
|
Brian Abrahams, M.D.
|
|
Sanford C. Bernstein & Co
|
Vincent Chen
|
|
Stifel
|
Paul Matteis
|
|
Truist Securities
|
Robyn Karnauskas
|
|
UBS Securities
|
Colin Bristow
|
Vertex Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Vertex Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vertex Pharmaceuticals or its management. Vertex Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.